Scotia Capital’s Lam Research LRCX Stock Holding History

Scotia Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.2M	Buy	300,456 +250,202	+498%	+$55.9M	0.26%	65
2025 Q4	$8.6M	Buy	50,254 +38,639	+333%	+$6.01M	0.03%	226
2025 Q3	$1.56M	Buy	11,615 +253	+2%	+$26.8K	0.01%	493
2025 Q2	$1.11M	Sell	11,362 -9,284	-45%	-$736K	0.01%	513
2025 Q1	$1.5M	Sell	20,646 -9,005	-30%	-$709K	0.01%	446
2024 Q4	$2.14M	Sell	29,651 -19	-0.1%	-$1.44K	0.01%	398
2024 Q3	$2.42M	Sell	29,670 -4,440	-13%	-$386K	0.01%	361
2024 Q2	$3.63M	Buy	34,110 +6,650	+24%	+$638K	0.02%	303
2024 Q1	$2.67M	Buy	27,460 +12,810	+87%	+$1.13M	0.02%	342
2023 Q4	$1.15M	Buy	14,650 +260	+2%	+$17.7K	0.01%	437
2023 Q3	$902K	Sell	14,390 -2,310	-14%	-$152K	0.01%	465
2023 Q2	$1.07M	Buy	16,700 +4,890	+41%	+$276K	0.01%	431
2023 Q1	$626K	Sell	11,810 -6,760	-36%	-$332K	﹤0.01%	513
2022 Q4	$781K	Sell	18,570 -31,920	-63%	-$1.34M	0.01%	487
2022 Q3	$1.85M	Buy	50,490 +4,570	+10%	+$203K	0.01%	348
2022 Q2	$1.96M	Sell	45,920 -5,800	-11%	-$276K	0.01%	360
2022 Q1	$2.78M	Sell	51,720 -7,370	-12%	-$429K	0.02%	348
2021 Q4	$4.25M	Sell	59,090 -3,300	-5%	-$207K	0.03%	286
2021 Q3	$3.55M	Sell	62,390 -22,320	-26%	-$1.36M	0.03%	291
2021 Q2	$5.51M	Buy	84,710 +20,400	+32%	+$1.29M	0.04%	239
2021 Q1	$3.83M	Buy	64,310 +37,310	+138%	+$2.03M	0.03%	271
2020 Q4	$1.27M	Sell	27,000 -55,770	-67%	-$2.35M	0.01%	400
2020 Q3	$2.75M	Sell	82,770 -3,200	-4%	-$110K	0.03%	254
2020 Q2	$2.78M	Buy	85,970 +57,400	+201%	+$1.57M	0.04%	224
2020 Q1	$686K	Sell	28,570 -7,720	-21%	-$222K	0.01%	388
2019 Q4	$1.06M	Sell	36,290 -8,850	-20%	-$235K	0.01%	385
2019 Q3	$1.04M	Buy	45,140 +2,530	+6%	+$53.1K	0.01%	380
2019 Q2	$800K	Buy	+42,610	New	+$808K	0.01%	444
2019 Q1	–	Sell	-32,630	Closed	-$444K	–	710
2018 Q4	$444K	Sell	32,630 -38,290	-54%	-$549K	0.01%	482
2018 Q3	$1.08M	Buy	70,920 +37,670	+113%	+$643K	0.01%	389
2018 Q2	$668K	Hold	33,250	–	–	0.01%	456
2018 Q1	$675K	Buy	33,250 +4,710	+17%	+$93.3K	0.01%	466
2017 Q4	$525K	Buy	+28,540	New	+$561K	0.01%	520
2017 Q2	–	Sell	-175,060	Closed	-$2.25M	–	715
2017 Q1	$2.25M	Buy	175,060 +155,180	+781%	+$1.82M	0.04%	249
2016 Q4	$210K	Buy	+19,880	New	+$202K	﹤0.01%	730
2015 Q3	–	Sell	-46,000	Closed	-$337K	–	812
2015 Q2	$374K	Sell	46,000 -1,650	-3%	-$13K	0.01%	587
2015 Q1	$335K	Buy	47,650 +3,650	+8%	+$28.9K	0.01%	499
2014 Q4	$349K	Hold	44,000	–	–	0.01%	479
2014 Q3	$329K	Buy	+44,000	New	+$314K	0.01%	483

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scotia Capital's LRCX Position: Q1 2026 in Review

Scotia Capital increased its Lam Research (LRCX) stake by 498% in Q1 2026, buying an estimated $55.9M and bringing the position to 300,456 shares worth $64.2M. The position accounts for 0.26% of the portfolio, ranked #65.

Scotia Capital first reported a position in LRCX in Q3 2014 and has held it in 39 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Scotia Capital held 300,456 shares of Lam Research worth $64.2M as of Q1 2026.
Scotia Capital bought 250,202 Lam Research shares in Q1 2026, an estimated $55.9M.
Lam Research made up 0.26% of Scotia Capital's portfolio in Q1 2026, its #65 holding.
Scotia Capital first reported a position in Lam Research in Q3 2014 and has held it in 39 quarters since.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.